Aducanumab: the beginning of the end of Alzheimer’s disease?
HULTON ARCHIVE/GETTY IMAGES
If approved, aducanumab won't end Alzheimer's because it cures the disease. It doesn't do that. But it will treat our Alzheimer's culture.
Suscribirse a:
Enviar comentarios (Atom)
No hay comentarios:
Publicar un comentario